Pfizer's 2025 DEF 14A: Executive Pay & 2024 Financials

Ticker: PFE · Form: DEF 14A · Filed: Mar 13, 2025 · CIK: 78003

Pfizer Inc DEF 14A Filing Summary
FieldDetail
CompanyPfizer Inc (PFE)
Form TypeDEF 14A
Filed DateMar 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, executive-compensation, corporate-governance, annual-filing

Related Tickers: PFE

TL;DR

Pfizer's 2025 DEF 14A is out, detailing exec pay and 2024 financials. Vote wisely.

AI Summary

Pfizer Inc. filed its DEF 14A on March 13, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Key financial data for the fiscal years 2020 through 2024 are presented, including information on equity awards and pension values for the 2023 and 2024 fiscal years.

Why It Matters

This filing provides shareholders with crucial information regarding executive compensation and corporate governance, enabling informed voting decisions on company leadership and strategy.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) that provides information to shareholders and does not inherently present new risks.

Key Numbers

  • 2024 — Fiscal Year End (Most recent fiscal year for which data is presented)
  • 2020-2024 — Financial Data Range (Period covered by the financial information in the filing)

Key Players & Entities

  • Pfizer Inc. (company) — Filer of the DEF 14A
  • 20250313 (date) — Filing date
  • 20250424 (date) — Period of report
  • 1231 (date) — Fiscal year end

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.

When was this specific DEF 14A filing by Pfizer Inc. submitted?

This DEF 14A filing by Pfizer Inc. was submitted on March 13, 2025.

What fiscal year does this filing primarily cover?

This filing primarily covers the fiscal year ending December 31, 2024, with comparative data from previous years.

What type of information is typically detailed in a DEF 14A filing regarding compensation?

DEF 14A filings detail executive compensation, including salaries, bonuses, stock awards, and other benefits, as well as the rationale behind these compensation decisions.

Where is Pfizer Inc. headquartered?

Pfizer Inc. is headquartered at 66 Hudson Boulevard East, New York, NY 10001-2192.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 13, 2025 regarding PFIZER INC (PFE).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.